Fluorine-18 fluorodeoxyglucose PET/CT is a suitable instrument to show the effects of lipid metabolism disorders on metabolic networks in the living organism

J Nucl Cardiol. 2022 Jun;29(3):1415-1418. doi: 10.1007/s12350-021-02543-8. Epub 2021 Feb 24.

Authors

Oana C Kulterer¹, Marcus Hacker²

Affiliations

¹ Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
² Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. [email protected].

PMID: 33629248
DOI: 10.1007/s12350-021-02543-8

No abstract available

Publication types

Editorial
Comment

MeSH terms

Fluorine Radioisotopes
Fluorodeoxyglucose F18*
Humans
Lipid Metabolism
Lipid Metabolism Disorders*
Metabolic Networks and Pathways
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Radiopharmaceuticals

Substances

Fluorine Radioisotopes
Radiopharmaceuticals
Fluorodeoxyglucose F18
Fluorine-18